

[6]
Hsieh JJ, Chen D, Wang PI, et al. Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma. Eur Urol 2017;71:405–14.
Ye Lei
a,b
Jens Mundhenk
a
Christian Schwentner
a,
*
a
Department of Urology, Diakonie Klinikum Stuttgart, Stuttgart, Germany
b
Department of Urology, Xiangya Hospital of Central South University,
Changsha, P.R. China
*Corresponding author. Department of Urology, Diakonie Klinikum
Stuttgart, Stuttgart, Germany.
E-mail address:
schwentner@diak-stuttgart.de(C. Schwentner).
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) e 1 8 0 – e 1 8 1
e181